About
Tests
Resources
News
Contact
Download Test Order Form

Order Tests Now

National Cancer Center $397,000 Grant

by pesbm-sam | Feb 1, 2022 | Industry | 0 comments

The National Cancer Institute awards $397,000 grant to Precision Epigenomics

Search

Recent Posts

Precision Epigenomics Highlighted by Tucson News 13 for Multi-Cancer Early Detection Blood Test Development
Precision Epigenomics Shares Abstracts Showing Performance of Assays for Melanoma and Brain Cancer Detection
Precision Epigenomics Announces Closing of $1.5M Series A1 Funding
Precision Epigenomics Receives $2M Award from National Institutes of Health
2024 Flinn Foundation Bioscience Entrepreneurship Program Partner

Recent Comments

No comments to show.

The EPISEEK™ test is recommended for use in adults with an elevated risk for cancer, such as those aged 45 or older. The EPISEEK™ test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. EPISEEK™ is intended to detect cancer signals. Use of EPISEEK™ is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.

Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of Cancer Signal Not Detected does not completely rule out cancer. A test result of Abnormal Methylation Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm or exclude the presence of cancer.

If cancer is not confirmed with further testing, it could mean that cancer is not present (i.e. EPISEEK™ false positive) or confirmatory testing was insufficient to detect a very early cancer (follow up testing false negative). False positive (abnormal methylation signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.

Quick Links

Home
About
Tests
Resources
News
Contact

Other Pages

Privacy Policy
Terms & Conditions
FCOI

Contact Info



630 N Alvernon Way
Ste 280B
Tucson, AZ 85711



520.372.7522



520.777.7367